Aptevo Therapeutics Inc.

APVO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.84

$0 (0.00%)

At close: Sep 21, 2026, 3:59 PM ET

$1.88

+$0.04 (+2.28%)

Pre-market: Sep 22, 2026, 4:14 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	21.62M	8.71M	16.9M	22.64M	45.04M	39.98M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	68K	746K
Receivables	n/a	n/a	n/a	2.5M	3.66M	2.37M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	853K	256K	689K	744K	2.04M	2.69M
Total Current Assets	23.08M	10.66M	19.07M	27.45M	52.57M	47.26M
Property-Plant & Equipment	4.11M	4.93M	5.78M	6.77M	3.96M	5.54M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.11M	4.93M	5.78M	6.77M	4.03M	6.28M
Total Assets	27.19M	15.59M	24.84M	34.22M	56.6M	53.55M
Account Payables	877K	3.05M	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	866K	n/a	n/a	2M	11.67M	5M
Other Current Liabilities	4.31M	3.15M	7.22M	6.71M	23.09M	9.54M
Total Current Liabilities	6.05M	6.21M	7.22M	8.71M	34.76M	14.54M
Long-Term Debt	n/a	n/a	n/a	1.46M	3.71M	20.05M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	15.58M	n/a
Total Long-Term Liabilities	3.76M	4.63M	5.4M	7.54M	20.63M	22.41M
Total Liabilities	9.81M	10.84M	12.62M	16.24M	55.39M	36.95M
Total Debt	4.63M	4.63M	5.4M	9.54M	16.72M	27.41M
Book Value	17.38M	4.76M	12.22M	17.97M	1.22M	16.59M
Book Value Per Share	5.51K	6.2K	585.43K	2.06M	152.02K	2.87M
Common Stock	114K	84K	61K	48K	47K	46K
Retained Earnings	-275.12M	-247.58M	-223.45M	-206.04M	-214.06M	-185.61M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	17.38M	4.76M	12.22M	17.97M	1.22M	16.59M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a